Prothena (PRTA) Earnings Date & Reports

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PRTA is expected to report earnings to rise 13.89% to -123 cents per share on May 07

Q1'25

Est.

$-1.23

Q4'24

Missed

by $0.08

Q3'24

Beat

by $0.08

Q2'24

Beat

by $2.28

Q1'24

Missed

by $0.16

The last earnings report on February 20 showed earnings per share of -108 cents, missing the estimate of -100 cents. With 60.84K shares outstanding, the current market capitalization sits at 653.46M.

View a ticker or compare two or three

Compare

PRTA